PRESS RELEASES

Jul 13, 2022

3D CARDIAC MAPPING SYSTEM TO IMPROVE HOW DOCTORS TREAT ABNORMAL HEART RHYTHMS NOW AVAILABLE IN CANADA

Abbott (NYSE: ABT) today announced it has introduced in Canada the EnSite™ X EP System with EnSite Omnipolar Technology (OT), a new cardiac mapping platform designed to help physicians better treat abnormal heart rhythms, also known as cardiac arrhythmias. This new platform allows for the creation of a 3D model of the patient's cardiac anatomy in real-time, improving how physicians identify and then treat areas of the heart where abnormal rhythms originate.